CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
基本信息
- 批准号:10454912
- 负责人:
- 金额:$ 48.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdultAffectAge-associated memory impairmentAgingAlzheimer&aposs DiseaseBehaviorBehavioralBindingBrainCellsChronicCognitionExcitatory SynapseGoalsHippocampus (Brain)HumanImageImpaired cognitionImpairmentIntrabodyKnock-in MouseLearningLong-Term EffectsLong-Term PotentiationMediator of activation proteinMemoryMonitorMovementMusMutant Strains MiceMutationN-Methyl-D-Aspartate ReceptorsNeurodegenerative DisordersNeuronsPathologicPhosphorylationPreventionProtein DephosphorylationProtein Phosphatase 2A Regulatory Subunit PR53ProteinsQuality of lifeRegulationRiskSynapsesSynaptic plasticityTestingTimeabeta oligomerage relatedagedaging populationcalmodulin-dependent protein kinase IIexpectationimprovedmutantnegative affectneuron lossnormal agingnovel therapeutic interventionprotein transportsynaptic function
项目摘要
Cognitive decline majorly affects quality of life in the general aging population; this is further exacerbated by an
increased risk for neurodegenerative diseases. The general age-related cognitive decline is thought to be
mainly due to impaired synaptic function, not loss of neurons. Similarly, while neurodegenerative diseases do
involve loss of neurons, there is also significantly impaired synaptic function in the surviving neurons, For
instance, amyloid β oligomers (Aβ) are major pathological agents in as Alzheimer's disease (AD) and cause
acute impairments in long-term potentiation (LTP) of excitatory synapses in the hippocampus, even at time
points and concentrations insufficient to induce any significant neuronal cell death. Here we will test our
hypotheses that the LTP impairments related to normal aging versus AD (i) both involve mis-regulation of the
Ca2+/calmodulin(CaM)-dependent protein kinase II (CaMKII), but (ii) by fundamentally different mechanisms to
(iii) result in the distinct forms of LTP impairment in normal aging versus AD. Specifically, we hypothesize that
CaMKII hypo-nitrosylation directly causes the impairments in aging, but not the Aβ-induced impairments
(which may instead even involve hyper-nitrosylation). Additionally, we hypothesize that hypo-nitrosylation
reduces LTP by chronic long-term effects on synapse composition (including CaMKII itself), while the Aβ effects
instead involve acute mis-regulation of CaMKII.
LTP is well-known to require CaMKII and its Ca2+-independent “autonomous” activity that is generated by
autophosphorylation of T286. Additionally, two alternative ways to generate autonomous activity have been
described by my lab: Binding to the NMDA-receptor subunit GluN2B and S-nitrosylation of C280+C289. Indeed,
CaMKII binding to GluN2B is also required for normal LTP and for the CaMKII movement to excitatory synapses
during LTP. The functions of CaMKII nitrosylation in LTP and other forms of synaptic plasticity will be elucidated
here. Intriguingly, previous studies have shown that aging is accompanied by hypo-nitrosylation of neuronal
proteins, including CaMKII, in both mice and humans. Additionally, preliminary studies indicated that
nitrosylation causes CaMKII movement to excitatory synapses, and that this requires regulated CaMKII binding
to GluN2B. i.e. the same mechanism that is required for the LTP-induced CaMKII movement.
In three related but independent aims, our proposal will determine the specific involvement of CaMKII
nitrosylation in the LTP impairments related to normal aging versus AD (with the expectation for fundamentally
distinct CaMKII mis-regulation). First, we will determine the regulatory mechanisms for synaptic CaMKII
localization by nitrosylation. Then, we will determine the functions of CaMKII nitrosylation in the distinct
impairment of LTP related to normal aging versus AD. Finally, we will determine the effects of CaMKII
nitrosylation on learning and memory function in behavioral tasks.
认知能力下降主要影响一般老龄化人群的生活质量;
神经退行性疾病的风险增加。一般认为,与年龄相关的认知能力下降
主要是由于突触功能受损,而不是神经元的损失。同样,虽然神经退行性疾病
涉及神经元的损失,在存活的神经元中也存在显著受损的突触功能,
例如,淀粉样蛋白β寡聚体(Aβ)是阿尔茨海默病(AD)主要病理因子,
海马兴奋性突触长时程增强(LTP)的急性损伤,即使在
点和浓度不足以诱导任何显著的神经元细胞死亡。在这里,我们将测试我们的
假设LTP损伤与正常衰老相对于AD(i)都涉及对LTP的错误调节,
Ca 2 +/钙调素(CaM)依赖性蛋白激酶II(CaMKII),但(ii)通过根本不同的机制,
(iii)导致正常老化与AD中不同形式的LTP损伤。具体来说,我们假设,
CaMKII亚亚硝基化直接导致衰老损伤,而不是Aβ诱导的损伤
(其甚至可替代地涉及超亚硝基化)。此外,我们假设亚亚硝基化
通过对突触成分(包括CaMKII本身)的慢性长期影响降低LTP,而Aβ影响
而是涉及CaMKII急性错误调节。
众所周知,LTP需要CaMKII及其由Ca 2+产生的非Ca 2+依赖性“自主”活性,
T286的自磷酸化。此外,还有两种生成自主活动的替代方法
与NMDA受体亚基GluN 2B的结合和C280+C289的S-亚硝基化。的确,
CaMK Ⅱ与GluN 2B的结合也是正常LTP和CaMK Ⅱ向兴奋性突触运动所必需的
在LTP期间。CaMKII亚硝酰化在LTP和其他形式的突触可塑性中的功能将被阐明
这里.有趣的是,以前的研究表明,衰老伴随着神经元的亚亚硝基化,
蛋白质,包括CaMKII,在小鼠和人类。此外,初步研究表明,
亚硝基化导致CaMKII运动到兴奋性突触,这需要调节CaMKII结合
GluN2B即LTP诱导的CaMKII运动所需的相同机制。
在三个相关但独立的目标中,我们的建议将确定CaMKII的具体参与
与正常衰老相关的LTP损伤中的亚硝基化与AD相比(预期从根本上
不同的CaMKII错误调节)。首先,我们将确定突触CaMKII的调节机制,
通过亚硝基化定位。然后,我们将确定CaMK II亚硝基化在不同的细胞中的功能,
与正常衰老相比,AD患者LTP受损。最后,我们将确定CaMKII的影响,
亚硝基化对行为任务中学习记忆功能的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
K. Ulrich Bayer其他文献
K. Ulrich Bayer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('K. Ulrich Bayer', 18)}}的其他基金
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention
CaMKII 在全脑缺血中的作用:机制和治疗干预
- 批准号:
10531925 - 财政年份:2021
- 资助金额:
$ 48.95万 - 项目类别:
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention
CaMKII 在全脑缺血中的作用:机制和治疗干预
- 批准号:
10328983 - 财政年份:2021
- 资助金额:
$ 48.95万 - 项目类别:
CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
- 批准号:
10222559 - 财政年份:2020
- 资助金额:
$ 48.95万 - 项目类别:
CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
- 批准号:
10671685 - 财政年份:2020
- 资助金额:
$ 48.95万 - 项目类别:
CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
- 批准号:
10444721 - 财政年份:2020
- 资助金额:
$ 48.95万 - 项目类别:
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction
β淀粉样蛋白诱导的突触功能障碍中的突触后激酶/磷酸酶网络
- 批准号:
10450777 - 财政年份:2018
- 资助金额:
$ 48.95万 - 项目类别:
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction
β淀粉样蛋白诱导的突触功能障碍中的突触后激酶/磷酸酶网络
- 批准号:
10207804 - 财政年份:2018
- 资助金额:
$ 48.95万 - 项目类别:
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction
β淀粉样蛋白诱导的突触功能障碍中的突触后激酶/磷酸酶网络
- 批准号:
9791023 - 财政年份:2018
- 资助金额:
$ 48.95万 - 项目类别:
Restoring synaptic function in Down Syndrome mice
恢复唐氏综合症小鼠的突触功能
- 批准号:
9340289 - 财政年份:2016
- 资助金额:
$ 48.95万 - 项目类别:
Restoring synaptic function in Down Syndrome mice
恢复唐氏综合症小鼠的突触功能
- 批准号:
9243583 - 财政年份:2016
- 资助金额:
$ 48.95万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 48.95万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 48.95万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 48.95万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 48.95万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 48.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 48.95万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 48.95万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 48.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 48.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 48.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)